| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRSK | Common Stock | Options Exercise | $1.25M | +20.5K | +95.25% | $61.14 | 42K | Dec 20, 2021 | Direct | |
| transaction | VRSK | Common Stock | Sale | -$64.4K | -300 | -0.71% | $214.71 | 41.7K | Dec 20, 2021 | Direct | F1 |
| transaction | VRSK | Common Stock | Sale | -$86.4K | -400 | -0.96% | $216.02 | 41.3K | Dec 20, 2021 | Direct | F2 |
| transaction | VRSK | Common Stock | Sale | -$997K | -4.6K | -11.14% | $216.82 | 36.7K | Dec 20, 2021 | Direct | F3 |
| transaction | VRSK | Common Stock | Sale | -$1.74M | -7.97K | -21.72% | $217.98 | 28.7K | Dec 20, 2021 | Direct | F4 |
| transaction | VRSK | Common Stock | Sale | -$1.58M | -7.21K | -25.12% | $219.18 | 21.5K | Dec 20, 2021 | Direct | F5 |
| holding | VRSK | Common Stock | 57K | Dec 20, 2021 | By Trust | F6 | |||||
| holding | VRSK | Common Stock | 9.03K | Dec 20, 2021 | By Trust | F7 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | VRSK | Stock Option | Options Exercise | $0 | -20.5K | -100% | $0.00* | 0 | Dec 20, 2021 | Common Stock | 20.5K | $61.14 | Direct | F8, F9 |
| Id | Content |
|---|---|
| F1 | These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $214.56 to $215.00, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (1). |
| F2 | These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $215.80 to $216.43, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (2). |
| F3 | These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $216.77 to $217.54, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (3). |
| F4 | These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $217.56 to $218.46, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (4). |
| F5 | These shares were sold pursuant to a 10b5-1 plan entered into by Mr. Anquillare on November 11, 2021. This sale price is a weighted average sale price that represents the sale of these shares of Common Stock at prices ranging from $218.57 to $219.55, inclusive. The reporting person undertakes to provide upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares of Common Stock sold at each separate price within the ranges set forth in this footnote (5). |
| F6 | These shares of common stock are held by the Mark Anquillare Spousal Living Trust. |
| F7 | These shares of common stock are held in a Revocable Trust. |
| F8 | This stock option was granted under the Issuer's 2009 Equity Incentive Plan. |
| F9 | Immediately. |